Background Concurrent head-to-head comparisons of healthcare interventions regarding
cost-utility are rare. The concept of favorable cost-effectiveness of total hip or knee arthroplasty …

Background and Objectives Five-tumour necrosis factor (TNF)-blockers (infliximab,
etanercept, adalimumab, certolizumab pegol and golimumab) are available for treatment of …

Background and Objectives Economic evaluations provide information to aid the optimal
utilization of limited healthcare resources. Costs of biologics for Rheumatoid arthritis (RA) are …

Background An automated dose dispensing (ADD) service has been implemented in primary
healthcare in some European countries. In this service, regularly used medicines are …

Objective. Because of the role of tumor necrosis factor (TNF) in host defense, it was hypothesized
that its inhibition might lead to an increased risk of malignancies and infections. The …

Background Co-morbidity is a powerful predictor of health care outcomes and costs, as well
as an important cofounder in epidemiologic studies. The effect of co-morbidities is generally …

Background The use of a restrictive formulary, with placement determined through a drug-reimbursement
decision-making process, is one approach to managing drug expenditures. …

Background If decisions on health care spending are to be as rational and objective as
possible, knowledge on cost-effectiveness of routine care is essential. Our aim, therefore, was to …

Background Several quality-of-life studies in patients awaiting major joint replacement have
focused on the outcomes of surgery. Interest in examining patients on the elective waiting …

Objective. The aim of this research was to describe the effectiveness and drug survival of
tumor necrosis factor (TNF) inhibitors in the treatment of ankylosing spondylitis (AS) and to …